Nebula Biocides GmbH
PrivateLast Round
Grant
Oct 1, 2023
Total Funding Raised
$2.37M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nebula Biocides GmbH operates in Healthcare & Life Sciences and is based in Greifswald. Its latest recorded funding round was a Grant round in October 2023.
Nebula Biocides GmbH is a biotechnology company that develops disinfection processes and products, including the Sporosan®-technology, designed to provide effective protection against infectious pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nebula Biocides GmbH Comparables
Compare Nebula Biocides GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Virox Technologies Inc. | 74% | |
| TOMI Environmental Solutions | 70% | |
| Paul Hartmann AG | 69% |
For institutional investors. Book with your work email.
Nebula Biocides GmbH Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nebula Biocides GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Regional Development Fund | Grant |
| Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern mbH | Seed |
| High-Tech Gründerfonds | Seed |
| State of Mecklenburg-Vorpommern | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 45% MoM.
- Jul 29, 2026
Monthly visitors grew 233% MoM, from 52 to 173.
For institutional investors. Book with your work email.
Nebula Biocides GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nebula Biocides GmbH's valuation, stock price, and market status.
Is Nebula Biocides GmbH a public or private company?
Nebula Biocides GmbH is a private company.
What is the current stock price of Nebula Biocides GmbH?
Nebula Biocides GmbH is a private company, so its shares have no public market price. Caplight tracks Nebula Biocides GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nebula Biocides GmbH worth (valuation)?
Valuation information for Nebula Biocides GmbH is not publicly available.
Can I buy Nebula Biocides GmbH stock?
Nebula Biocides GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nebula Biocides GmbH's last funding round?
Nebula Biocides GmbH's most recent funding round was Grant on October 1, 2023.
Who are the main investors in Nebula Biocides GmbH?
Key investors in Nebula Biocides GmbH include European Regional Development Fund, Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern mbH, High-Tech Gründerfonds, State of Mecklenburg-Vorpommern.
Will Nebula Biocides GmbH IPO soon?
No public IPO plans have been announced for Nebula Biocides GmbH.
How can I track Nebula Biocides GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Nebula Biocides GmbH's shares on secondary markets.